A carregar...
Galectin-9 and PSMB8 overexpression predict unfavorable prognosis in patients with AML
Acute myeloid leukemia (AML) is a deadly heterogeneous hematologic malignancy. Despite the well-characterized genetic characteristics and new promising targeted therapies for AML, the clinical outcome remains suboptimal. Galectin-9 (Gal-9) is a good potential target due to its immunosuppressive capa...
Na minha lista:
| Publicado no: | J Cancer |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8176406/ https://ncbi.nlm.nih.gov/pubmed/34093826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.53686 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|